Clinical trial
Defining the Role of ctDNA Monitoring in a Risk Stratified Clinical Trial for Posttransplant Lymphoproliferative Disorder (PTLD)
NCT06954805 is registered in ClinicalTrials.gov with Jennifer Amengual as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Defining the Role of ctDNA Monitoring in a Risk Stratified Clinical Trial for Posttransplant Lymphoproliferative Disorder (PTLD)
- Lead sponsor
- Jennifer Amengual
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- April 14, 2025
- Completion date
- April 14, 2028
- Enrollment
- 30 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.